Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
August 18, 2015
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
Lijie Zhai, Mahua Dey, Kristen L Lauing, et al.
Molecular Cancer Therapeutics
|
October 15, 2014
NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification
Yasuyuki Yoshida, Tomoko Ozawa, Tsun-Wen Yao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
Patrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Neuro-Oncology
|
November 12, 2019
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas
Michael R Drumm, Karan S Dixit, Sean Grimm, et al.
Annals of Neurology
|
April 6, 2006
International study on low-grade primary central nervous system lymphoma
Kristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2023
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Samuel J Klempner, Keun-Wook Lee, Kohei Shitara, et al.
Neuro-Oncology
|
August 8, 2018
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression
Raymond Y Huang, Prashin Unadkat, Wenya Linda Bi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2008
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme
David A Reardon, Karen L Fink, Tom Mikkelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
Journal of Oncology Practice
|
December 4, 2014
Economics of Malignant Gliomas: A Critical Review
Jeffrey J Raizer, Karen A Fitzner, Daniel I Jacobs, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
August 18, 2015
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
Lijie Zhai, Mahua Dey, Kristen L Lauing, et al.
Molecular Cancer Therapeutics
|
October 15, 2014
NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification
Yasuyuki Yoshida, Tomoko Ozawa, Tsun-Wen Yao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome
Patrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Neuro-Oncology
|
November 12, 2019
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas
Michael R Drumm, Karan S Dixit, Sean Grimm, et al.
Annals of Neurology
|
April 6, 2006
International study on low-grade primary central nervous system lymphoma
Kristoph Jahnke, Agnieszka Korfel, Brian Patrick O'Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2023
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Samuel J Klempner, Keun-Wook Lee, Kohei Shitara, et al.
Neuro-Oncology
|
August 8, 2018
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression
Raymond Y Huang, Prashin Unadkat, Wenya Linda Bi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2008
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme
David A Reardon, Karen L Fink, Tom Mikkelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
Journal of Oncology Practice
|
December 4, 2014
Economics of Malignant Gliomas: A Critical Review
Jeffrey J Raizer, Karen A Fitzner, Daniel I Jacobs, et al.
Page
of 8